351 related articles for article (PubMed ID: 20508503)
1. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.
Haque RM; Torkildsen GL; Brubaker K; Zink RC; Kowalski RP; Mah FS; Pflugfelder SC
Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis.
Luchs J
Adv Ther; 2008 Sep; 25(9):858-70. PubMed ID: 18781287
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.
Opitz DL; Tyler KF
Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761
[TBL] [Abstract][Full Text] [Related]
4. Oral azithromycin for treatment of posterior blepharitis.
Igami TZ; Holzchuh R; Osaki TH; Santo RM; Kara-Jose N; Hida RY
Cornea; 2011 Oct; 30(10):1145-9. PubMed ID: 21849891
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
[TBL] [Abstract][Full Text] [Related]
7. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Efficacy of Topical and Systemic Azithromycin Treatment for Posterior Blepharitis.
Yildiz E; Yenerel NM; Turan-Yardimci A; Erkan M; Gunes P
J Ocul Pharmacol Ther; 2018 May; 34(4):365-372. PubMed ID: 29493395
[TBL] [Abstract][Full Text] [Related]
9. Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness.
Veldman P; Colby K
Int Ophthalmol Clin; 2011; 51(4):43-52. PubMed ID: 21897139
[No Abstract] [Full Text] [Related]
10. Eyelid margin modification associated with eyelid hygiene in anterior blepharitis and meibomian gland dysfunction.
Guillon M; Maissa C; Wong S
Eye Contact Lens; 2012 Sep; 38(5):319-25. PubMed ID: 22890229
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
Bremond-Gignac D; Mariani-Kurkdjian P; Beresniak A; El Fekih L; Bhagat Y; Pouliquen P; Delval L; Goldschmidt P; Bingen E; Cochereau I
Pediatr Infect Dis J; 2010 Mar; 29(3):222-6. PubMed ID: 19935122
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis].
Robert PY; Bourcier T; Meddeb-Ouertani A; Khairallah M; Zaghloul K; Amraoui A; Bhagat Y; Pop M; Cochereau I
J Fr Ophtalmol; 2010 Apr; 33(4):241-8. PubMed ID: 20223555
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
[TBL] [Abstract][Full Text] [Related]
14. Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis.
John T; Shah AA
Ann Ophthalmol (Skokie); 2008; 40(2):68-74. PubMed ID: 19013912
[TBL] [Abstract][Full Text] [Related]
15. Topical azithromycin as a novel treatment for ocular rosacea.
Mantelli F; Di Zazzo A; Sacchetti M; Dianzani C; Lambiase A; Bonini S
Ocul Immunol Inflamm; 2013 Oct; 21(5):371-7. PubMed ID: 23875944
[TBL] [Abstract][Full Text] [Related]
16. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease.
Zhang L; Su Z; Zhang Z; Lin J; Li DQ; Pflugfelder SC
JAMA Ophthalmol; 2015 Oct; 133(10):1117-23. PubMed ID: 26204109
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
[TBL] [Abstract][Full Text] [Related]
18. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
19. Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin.
Bakar O; Demircay Z; Toker E; Cakir S
J Eur Acad Dermatol Venereol; 2009 May; 23(5):544-9. PubMed ID: 19250326
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Azithromycin Eyedrops for Individuals With Meibomian Gland Dysfunction-Associated Posterior Blepharitis.
Arita R; Fukuoka S
Eye Contact Lens; 2021 Jan; 47(1):54-59. PubMed ID: 32649390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
